Patent details

Basic Information

Publication number:

EP3174526

PCT Application Number:

EP2015001577

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP157667452

PCT Publication Number:

WO2016015875

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMPOSITION CONTAINING APOMORPHINE AND A DIVALENT METAL CATION

French Title of Invention:

COMPOSITION CONTENANT DE L'APOMORPHINE ET UN CATION DE MÉTAL DIVALENT

German Title of Invention:

ZUSAMMENSETZUNG MIT APOMORPHIN UND DIVALENTEM METALLKATION

SPC Number:

Dates

Filing date:

31/07/2015

Grant date:

11/09/2019

EP Publication Date:

07/06/2017

PCT Publication Date:

04/02/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

11/09/2019

EP B1 Publication Date:

11/09/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

31/07/2020

Expiration date:

31/07/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

04/09/2019

 

 

Name:

Britannia Pharmaceuticals Limited

Address:

200 Longwater Avenue Green Park, Reading, Berkshire RG2 6GP, United Kingdom (GB)

Inventor

Name:

LEADER, Ian Philip

Address:

United Kingdom (GB)

Priority

Priority Number:

14002689

Priority Date:

01/08/2014

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

A61K 9/08; A61K 31/473; A61K 47/02; A61P 25/16;

Publication

European Patent Bulletin

1

Issue number:

201937

Publication date:

11/09/2019

Description:

Grant (B1)

2

Issue number:

202029

Publication date:

15/07/2020

Description:

Opposition procedure started

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages